Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b

Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus

(2021) Federica Petrillo et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The SGLT2-inhibitor dapagliflozin improves neutropenia and neutrophil dysfunction in a mouse model of the inherited metabolic disorder GSDIb

(2021) Roberta Resaz et al.   Molecular Genetics and Metabolism Reports

Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor

(2020) Saskia B Wortmann et al.   BLOOD

Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway

(2020) Anna Iervolino et al.   Scientific Reports

Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation

(2020) Federica Prosperi et al.   Scientific Reports

Sex Differences in Diabetes- and TGF-β1-Induced Renal Damage

(2020) Nadja Ziller et al.   Cells

Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency

(2019) Maria Veiga-da-Cunha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glucose and glycogen in the diabetic kidney: Heroes or villains?

(2019) Mitchell A. Sullivan et al.   EBioMedicine

Development and characterization of an inducible mouse model for glycogen storage disease type Ib

(2018) Federica Raggi et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Integrin Beta 1 Is Crucial for Urinary Concentrating Ability and Renal Medulla Architecture in Adult Mice

(2018) Anna Iervolino et al.   Frontiers in Physiology

Model analysis of effect of canagliflozin (Invokana), a sodium–glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol

(2016) Danielle Fortuna et al.   CLINICA CHIMICA ACTA

Intercalated Cell Depletion and Vacuolar H+-ATPase Mistargeting in an Ae1 R607H Knockin Model

(2016) Rizwan Mumtaz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Glycogen storage disease type III: A novel Agl knockout mouse model

(2014) Serena Pagliarani et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy

(2014) Julie Clar et al.   KIDNEY INTERNATIONAL

Armanni-Ebstein Lesions: A Need for Clarification

(2012) Chong Zhou et al.   JOURNAL OF FORENSIC SCIENCES

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus

(2012) Jean Whaley et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

SGLT2 inhibition — a novel strategy for diabetes treatment

(2010) Edward C. Chao et al.   NATURE REVIEWS DRUG DISCOVERY

Globally optimal stitching of tiled 3D microscopic image acquisitions

(2009) S. Preibisch et al.   BIOINFORMATICS

Vitamin E supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b

(2008) D. Melis et al.   EUROPEAN JOURNAL OF PEDIATRICS